Hello, I am currently using Partek Genomic Suite Software to analyze smallRNA Seq data for miRNA analysis. I unfortunately do not have biological replicates of my two experimental groups (disease and control) and was wondering what statistical options I have when it comes to detecting differential expression. Partek automatically utilizes an ANOVA, so without any replicates I get a ? for each p-value. I know that going simply on fold-change is not enough so I would like to employ some statistical test to get a better idea of which of my miRNAs are significant.
Unconfigured Ad
Collapse
X
-
Hi,
It'll be very hard to expect any biological significance for any of your detected miRNAs without the presence of biological replicates (if you are planning to publish this data, you'll need biological replicates). Check the guidelines from the ENCODE project regarding the "best practices" for RNA-seq (most ideas should be the same for miRNA-seq) experiments.
As far as getting some p-values from the data you already have (no biological replicates), you could try using DESeq:
The Bioconductor project aims to develop and share open source software for precise and repeatable analysis of biological data. We foster an inclusive and collaborative community of developers and data scientists.
Just be cautious in making any significant claims about your experiment based on this.
I hope this helps!
-
Hi leeor,
In Partek Genomics Suite, during the Quantification step and in the absence of replicates a p-value is calculated for differential expression using a Log Likelihood Ratio test, but this is a very basic statistic as there is no variance component (which comes from having replicates).
Our tool for Differential Expression Analysis uses an ANOVA model which, in the absence of replicates, can calculate ratios and fold-changes, but not p-value as it cannot estimate variance.
If you have no chance to obtain replicates your only option is to perform the Quantification in Genomics Suite, filter the table on p-value (from the Log Likelihood Ratio test) and read count (raw or normalised), and validate expression via qPCR/dPCR or similar.
However at Partek we always recommend the use of true biological replicates as this is the only way to have confidence in your data.
Good luck!
Kind regards,
Scott (European FAS @ Partek)
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment